NCT02061800 2024-06-04CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantColumbia UniversityPhase 1/2 Active not recruiting14 enrolled
NCT03609827 2021-10-04Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant PatientsUniversity of California, San FranciscoCompleted25 enrolled